+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

From
From
Generic Injectables Market Report and Forecast 2023-2031 - Product Thumbnail Image

Generic Injectables Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 147 Pages
  • Global
From
Pen Needles Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Pen Needles Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Pharmaceuticals Market in Germany 2024-2028 - Product Thumbnail Image

Pharmaceuticals Market in Germany 2024-2028

  • Report
  • August 2024
  • 130 Pages
  • Germany
From
From
From
Pharmaceutical Drugs Industry: Global Competitive Landscape 2021 - Product Thumbnail Image

Pharmaceutical Drugs Industry: Global Competitive Landscape 2021

  • Report
  • October 2022
  • 307 Pages
  • Global
From
From
Transthyretin Amyloid Cardiomyopathy - Pipeline Inisght, 2021 - Product Thumbnail Image

Transthyretin Amyloid Cardiomyopathy - Pipeline Inisght, 2021

  • Clinical Trials
  • September 2021
  • 60 Pages
  • Global
From
Pharmaceutical Market in Denmark 2024-2028 - Product Thumbnail Image

Pharmaceutical Market in Denmark 2024-2028

  • Report
  • February 2024
  • 139 Pages
  • Denmark
From
Glucagon-Like Peptide 1 Receptor Agonists - Pipeline Insight, 2024 - Product Thumbnail Image

Glucagon-Like Peptide 1 Receptor Agonists - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 100 Pages
  • Global
From
From
From
From
Loading Indicator